Short-Term Corticosteroid Therapy for Early Exacerbation of COVID-19 Pneumonia : A Case Report
BACKGROUND The effect of corticosteroids in the management of patients with coronavirus disease 2019 (COVID-19) is unclear. CASE REPORT A 67-year-old man who tested positive for COVID-19 by reverse-transcription PCR (RT-PCR) analysis was admitted to our hospital. On admission, he had no dyspnea and his oxygen saturation (SpO₂) level was normal. Chest imaging revealed ground-glass opacities (GGO) distributed in both lung fields. Four days after admission, bilateral lung shadows worsened, with a slight reduction in SpO₂ levels. Short-term corticosteroid therapy was initiated, and SpO₂ and radiographic findings promptly improved without use of antiviral agents. CONCLUSIONS More data are required to ascertain the role of corticosteroids in the management of COVID-19 pneumonia.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:21 |
---|---|
Enthalten in: |
The American journal of case reports - 21(2020) vom: 14. Aug., Seite e924476 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Urano, Akira [VerfasserIn] |
---|
Links: |
---|
Themen: |
Case Reports |
---|
Anmerkungen: |
Date Completed 01.09.2020 Date Revised 18.12.2020 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.12659/AJCR.924476 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM313714452 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM313714452 | ||
003 | DE-627 | ||
005 | 20231225151150.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.12659/AJCR.924476 |2 doi | |
028 | 5 | 2 | |a pubmed24n1045.xml |
035 | |a (DE-627)NLM313714452 | ||
035 | |a (NLM)32796809 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Urano, Akira |e verfasserin |4 aut | |
245 | 1 | 0 | |a Short-Term Corticosteroid Therapy for Early Exacerbation of COVID-19 Pneumonia |b A Case Report |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 01.09.2020 | ||
500 | |a Date Revised 18.12.2020 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a BACKGROUND The effect of corticosteroids in the management of patients with coronavirus disease 2019 (COVID-19) is unclear. CASE REPORT A 67-year-old man who tested positive for COVID-19 by reverse-transcription PCR (RT-PCR) analysis was admitted to our hospital. On admission, he had no dyspnea and his oxygen saturation (SpO₂) level was normal. Chest imaging revealed ground-glass opacities (GGO) distributed in both lung fields. Four days after admission, bilateral lung shadows worsened, with a slight reduction in SpO₂ levels. Short-term corticosteroid therapy was initiated, and SpO₂ and radiographic findings promptly improved without use of antiviral agents. CONCLUSIONS More data are required to ascertain the role of corticosteroids in the management of COVID-19 pneumonia | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a Journal Article | |
650 | 7 | |a Glucocorticoids |2 NLM | |
650 | 7 | |a Oxygen |2 NLM | |
650 | 7 | |a S88TT14065 |2 NLM | |
650 | 7 | |a Methylprednisolone |2 NLM | |
650 | 7 | |a X4W7ZR7023 |2 NLM | |
700 | 1 | |a Kasai, Hajime |e verfasserin |4 aut | |
700 | 1 | |a Murai, Yushi |e verfasserin |4 aut | |
700 | 1 | |a Ikeda, Hideki |e verfasserin |4 aut | |
700 | 1 | |a Urushibara, Takashi |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t The American journal of case reports |d 2009 |g 21(2020) vom: 14. Aug., Seite e924476 |w (DE-627)NLM226518345 |x 1941-5923 |7 nnns |
773 | 1 | 8 | |g volume:21 |g year:2020 |g day:14 |g month:08 |g pages:e924476 |
856 | 4 | 0 | |u http://dx.doi.org/10.12659/AJCR.924476 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 21 |j 2020 |b 14 |c 08 |h e924476 |